On May 15, 2014, Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, reported unaudited first quarter fiscal year 2014 earnings, for the period ended March 31, 2014. For the year ended March 31, 2014, Skystar’s revenues were roughly $6.8 million as compared to revenues of $5.5 million for the three months ended March 31, 2013, an increase of $1.3 million or 23.5%. Overall increase in revenue was due to increase in manufacturing at the Company’s Huxian plant in combination with receiving product permits by the Ministry of Agriculture to manufacture select veterinary medications. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), net profit margin is 24.70% and weekly performance is 8.44%. On last trading day company shares ended up $7.71. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), distance from 50-day simple moving average (SMA50) is 26.31%.
On June 26, 2014, Manulife Financial Corporation (USA) (NYSE:MFC), is pleased to announce that a final prospectus for Manulife U.S. Regional Bank Trust (the “Fund”) has been filed and receipted by the securities regulatory authorities of all the Canadian provinces and territories for an initial public offering (the “Offering”) of Class A Units and Class U Units of the Fund (collectively, the “Units”) at a price of $10.00 per Class A Unit and US$10.00 per Class U Unit. Manulife Financial Corporation (USA) (NYSE:MFC), advanced 1.30% in last trading session and ended the day on $20.33. MFC, return on assets is 0.60%. Manulife Financial Corporation (USA) (NYSE:MFC), quarterly performance is 4.90%.
Mitsui & Co Ltd (ADR) (OTCMKTS:MITSY), shares moved down 0.19% in last trading session and was closed at $325.30, while trading in range of $324.75 – 326.23.
On June 30, 2014, Garmin Ltd. (NASDAQ:GRMN), invites shareholders and investors to listen to its second quarter 2014 earnings conference call that will be broadcast over the Internet on Wednesday, July 30, 2014 at 10:30 a.m. ET, with executives of Garmin. The call will be held in conjunction with the company’s earnings release, which will be distributed prior to market open on July 30, 2014. Garmin Ltd. (NASDAQ:GRMN), ended the last trading day at $61.69. Company weekly volatility is calculated as 1.79% and price to cash ratio as 9.24. Garmin Ltd. (NASDAQ:GRMN), showed a positive weekly performance of 4.15%.
Leave a Reply